EMA committee recommends restrictions on fluoroquinolone, quinolone antibiotics Antibiotics, Birth Defects, Blockbusters, Bones, Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMA), FDA, FDA/Regulatory, Fluoroquinolones, Integrase inhibitors, Muscles, Nervous System, Pharmacovigilance Risk Assessment Committee (PRAC), Quinolone, Tendons The EMA’s risk assessment committee recommended restrictions on the use of the broad-spectrum antibiotics. Read more October 5, 2018/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2018-10-05 10:33:422018-10-05 13:27:54EMA committee recommends restrictions on fluoroquinolone, quinolone antibiotics
